Tailored Exercise Program for Cancer Patients
(PALS Trial)
Trial Summary
What is the purpose of this trial?
This trial tests whether exercise sessions or health workshops can help cancer patients maintain their fitness, heart function, memory, and quality of life during treatment.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, since the trial involves exercise and educational workshops, it is likely that you can continue your medications. It's best to discuss this with your doctor and the trial coordinators.
What data supports the idea that Tailored Exercise Program for Cancer Patients is an effective treatment?
The available research shows that tailored exercise programs for cancer patients can significantly improve their quality of life. For example, studies have found that exercise helps reduce fatigue and depression, which are common side effects of cancer treatment. In one study, patients with multiple myeloma who followed a home-based exercise program showed improvements in physical performance, while those who did not exercise experienced declines. Another study highlighted that 150 minutes of moderate aerobic activity per week can enhance survival rates and reduce treatment side effects. Overall, these findings suggest that exercise is a valuable part of cancer care, offering benefits that are comparable to other treatments.12345
What safety data exists for tailored exercise programs for cancer patients?
The research indicates that exercise is generally safe and beneficial for cancer patients, including those with breast, prostate, colorectal, and lung cancer. Studies highlight the efficacy and safety of tailored exercise interventions, such as computer-tailored and virtual exercise programs, for improving physical and psychological outcomes. However, there is a need for more extensive research on tailoring exercise to address specific cancer-related impairments to ensure safe participation.678910
Is the Tailored Physical Activity Intervention a promising treatment for cancer patients?
Research Team
William Hundley, MD
Principal Investigator
Wake Forest Baptist Comprehensive Cancer Center
Eligibility Criteria
This trial is for adults aged 18-85 with Hodgkin's or non-Hodgkin's lymphoma who can walk two city blocks and are expected to undergo certain cancer therapies. They must speak English, have a survival expectancy beyond 6 months, and an assistant for home-based activities. Exclusions include uncontrolled high blood pressure, MRI contraindications, recent heart attack, inability to exercise on treadmill/cycle, pregnancy, drug abuse history, inflammatory conditions or other safety-compromising medical issues.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either a Physical Activity Intervention or a Healthy Living Intervention for 6 months
Follow-up
Participants are monitored for changes in exercise capacity, heart function, and quality of life
Treatment Details
Interventions
- Tailored Physical Activity Intervention (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
Dr. L. Ebony Boulware
Wake Forest University Health Sciences
Chief Medical Officer since 2022
MD from Duke University School of Medicine, MPH from Johns Hopkins Bloomberg School of Public Health
Dr. Julie Ann Freischlag
Wake Forest University Health Sciences
Chief Executive Officer since 2020
BS from University of Illinois, MD from Rush University
National Cancer Institute (NCI)
Collaborator
Dr. Douglas R. Lowy
National Cancer Institute (NCI)
Chief Executive Officer since 2023
MD from New York University School of Medicine
Dr. Monica Bertagnolli
National Cancer Institute (NCI)
Chief Medical Officer since 2022
MD from Harvard Medical School